The TME consists of numerous pro-angiogenic factors, including vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF), which are secreted by tumor cells or tumor-infiltrating lymphocytes (TILs) or macrophages (8). This evidence concerns the gene VEGFA and neoplasm.